Atara Biotherapeutics (FRA:AT2) Other Long Term Assets : €4.44 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Atara Biotherapeutics Other Long Term Assets?

Atara Biotherapeutics's other long-term assets for the quarter that ended in Dec. 2023 was €4.44 Mil.

Atara Biotherapeutics's quarterly other long-term assets declined from Jun. 2023 (€6.07 Mil) to Sep. 2023 (€5.89 Mil) but then stayed the same from Sep. 2023 (€5.89 Mil) to Dec. 2023 (€4.44 Mil).

Atara Biotherapeutics's annual other long-term assets increased from Dec. 2021 (€3.16 Mil) to Dec. 2022 (€6.62 Mil) but then declined from Dec. 2022 (€6.62 Mil) to Dec. 2023 (€4.44 Mil).

Atara Biotherapeutics Other Long Term Assets Historical Data

The historical data trend for Atara Biotherapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atara Biotherapeutics Other Long Term Assets Chart

Atara Biotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

1.59

1.67

3.16

6.62

4.44

Atara Biotherapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															6.62	6.45	6.07	5.89	4.44

Atara Biotherapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Atara Biotherapeutics (FRA:AT2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atara Biotherapeutics Inc (FRA:AT2) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ATRA:USA AT2:Germany

Address

2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA, USA, 91320

Website

https://www.atarabio.com

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Atara Biotherapeutics (FRA:AT2) Headlines

No Headlines